During the past decade, Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont conducted 88 clinical trials. In the 10-year time frame, 88 clinical trials started and 73 clinical trials were completed, i.e. on average, 83% percent of trials that started reached the finish line to date. In the past 5 years, 35 clinical trials started and 43 clinical trials were completed. i.e. 122.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont" #1 sponsor was "Hoffmann-La Roche" with 18 trials, followed by "Pfizer" with 18 trials sponsored, "Takeda" with 10 trials sponsored, "Eli Lilly and Company" with 9 trials sponsored and "Celgene" with 9 trials sponsored. Other sponsors include 65 different institutions and companies that sponsored additional 55 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont" #1 collaborator was "Breast International Group" with 2 trials as a collaborator, "Chiltern International Inc." with 2 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "Incyte Corporation" with 2 trials as a collaborator and "Millennium Pharmaceuticals, Inc." with 2 trials as a collaborator. Other collaborators include 23 different institutions and companies that were collaborators in the rest 32 trials.

According to Clinical.Site data, the most researched conditions in "Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont" are "Ulcerative Colitis" (12 trials), "Breast Cancer" (9 trials), "Crohn's Disease" (8 trials), "Acromegaly" (4 trials) and "Rheumatoid Arthritis" (4 trials). Many other conditions were trialed in "Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont" in a lesser frequency.

Most popular intervention types in "Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont" are "Drug" (122 trials), "Other" (9 trials), "Biological" (8 trials), "Combination Product" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (41 trials), "Capecitabine" (7 trials), "Paclitaxel" (6 trials), "Pertuzumab" (6 trials) and "Trastuzumab" (6 trials). Other intervention names were less common.

The vast majority of trials in "Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont" are 115 trials for "All" genders, 11 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont". undefined are not yet recruiting, 18 are recruiting, 18 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 76 completed trials in Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont, undefined suspended trials, and 14 terminated clinical trials to date.

Out of the total trials that were conducted in Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont, 3 "Phase 1" clinical trials were conducted, 33 "Phase 2" clinical trials and 86 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 1 trials that are defined as “Not Applicable".